Effective testing is vitally important for diagnosis, prognosis, and disease management. With more than 90% of the 7,000 identified rare diseases lacking FDA-approved treatment,1 and patients waiting between 8 and 10 years before diagnosis,...
Mayo Clinic researchers identify new disease subtype linked to recurrent blood clots - Insights
Mayo Clinic researchers identify a new subtype of MGTS, linked to recurrent blood clots, with significant diagnostic challenges and treatment implications.
CPT codes and LOINC update: July 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of July.
Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.
CPT codes and LOINC update: September 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of September.
Mitochondrial disease - Insights
Learn about our four molecular testing options, which can be used to confirm a diagnosis and identify a specific mitochondrial syndrome.
Mayo Clinic Laboratory and Pathology Research Roundup: April 16 - Insights
This week's research roundup feature: R0 resection and radiation therapy have been associated with improved overall survival (OS) in patients with thymic carcinoma (TC). Here, we analyzed which subgroups of patients derive the greatest...
search - Mayo Clinic Laboratories
Search Results Site Search...
hereditary_peripheral_neuropathies_testing_algorithm.pdf
Inherited neuropathy suspected; Insidious onsets progressive (years)* The following tests should be performed in all adult patients: HbA1c or glucose tolerance, vitamin B12, monoclonal proteins. Order PMPDD / PMP22 Gene, Large Deletion...
Specific Drug Groups - Mayo Clinic Laboratories
Specific Drug Groups Use the following links to view information for specific drug categories: Alcohol Amphetamine-Type Stimulants...